Despite the high incidence of brain metastasis after resection of non-small cell lung cancer (NSCLC), the National Comprehensive Cancer Network guidelines do not recommend central nervous system (CNS) ...

The 10-week course at Stanford last fall was fully enrolled and packed with students eager to learn from Dr. Lin's unique ...

It can also help you feel confident that the plan you choose is the right one. Metastatic non-small-cell lung cancer isn’t curable. Treatment may be able to help you live longer and ease your ...

are conducting three clinical trials of new SRS strategies for patients with lung cancer brain metastases as follows: 1. SRS in Patients with SCLC and Newly-Diagnosed Brain Metastases This ...

The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...

Sydney, Australia Friday, March 28, 2025, 18:00 Hrs [IST] ...

The first patient has been dosed in the phase 3 TACTI-004 trial evaluating efti with Keytruda and chemotherapy for advanced ...

Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 and/or KEAP1 tumor suppressor ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ...